What are the diagnostic criteria for a renin-producing tumor (reninoma)?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: April 25, 2025View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

From the Guidelines

Diagnosing reninoma requires a comprehensive approach that includes clinical evaluation, laboratory tests, and imaging studies, with a focus on identifying the characteristic clinical triad of hypertension, hypokalemia, and elevated plasma renin activity. When suspecting a renal mass like reninoma, clinicians should obtain high-quality, multiphase, cross-sectional abdominal imaging to optimally characterize and clinically stage the renal mass, as recommended by the American Urological Association guideline 1. This approach should include:

  • Assessment of tumor complexity
  • Degree of contrast enhancement
  • Presence or absence of fat Additionally, a comprehensive metabolic panel, complete blood count, and urinalysis should be performed, along with chest imaging to evaluate for possible thoracic metastases 1. Evaluation for proteinuria, CKD, hematuria, hypercalcemia, hepatic dysfunction, and blood count abnormalities is also crucial, as these may reflect poor health status or advanced cancer. In the context of reninoma, specific laboratory tests such as measuring plasma renin activity or concentration, aldosterone levels, and the aldosterone-to-renin ratio can help confirm the diagnosis. Imaging studies like contrast-enhanced CT or MRI of the kidneys can detect reninomas, which are typically small, well-circumscribed masses within the kidney. Selective renal vein sampling for renin may be necessary to confirm the diagnosis and precisely locate the tumor, especially in cases where imaging results are inconclusive.

From the Research

Diagnostic Evaluation of Reninoma

To diagnose reninoma, several diagnostic approaches can be employed, including:

  • Imaging studies to identify the presence of a lesion in the renal cortex 2
  • Selective venous catheterization following administration of an angiotensin-converting enzyme inhibitor (ACE-I) to confirm the presence of a renin-producing lesion 2
  • Measurement of plasma renin activity (PRA) and aldosterone levels to assess for hypersecretion of renin 2, 3, 4, 5
  • Renal vein renin sampling with lateralization to identify the site of excessive renin production 4, 5
  • Contrast CT or magnetic resonance imaging of the kidneys to diagnose reninoma 4

Biochemical Markers

Biochemical markers that can aid in the diagnosis of reninoma include:

  • Elevated plasma renin activity (PRA) 2, 3, 4, 5
  • Elevated aldosterone levels 2, 3, 4, 5
  • Hypokalemia and metabolic alkalosis on the first blood sample drawn before any treatment is instituted 4

Imaging Modalities

Imaging modalities that can be used to diagnose reninoma include:

  • Renal ultrasound, although it may miss reninoma 4
  • Contrast CT or magnetic resonance imaging of the kidneys 4
  • Renal CT to detect the lesion 5
  • Retroperitoneal laparoscopic partial nephrectomy for surgical removal of reninoma 6

References

Guideline

Guideline Directed Topic Overview

Dr.Oracle Medical Advisory Board & Editors, 2025

Research

Reninoma: case report and literature review.

Journal of hypertension, 2008

Research

Approach to the Patient: Reninoma.

The Journal of clinical endocrinology and metabolism, 2024

Research

Minimally Invasive Surgery-Based Multidisciplinary Clinical Management of Reninoma: A Single-Center Study.

Medical science monitor : international medical journal of experimental and clinical research, 2019

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.